Skip to main content
PLOS Global Public Health logoLink to PLOS Global Public Health
. 2023 Dec 8;3(12):e0002022. doi: 10.1371/journal.pgph.0002022

Using electronic medical records to understand the impact of SARS-CoV-2 lockdown measures on maternal and neonatal outcomes in Kampala, Uganda

Joseph Ouma 1, Lauren Hookham 2,*, Lorna Aol Akera 1, Gordon Rukundo 1, Mary Kyohere 1, Ayoub Kakande 3, Racheal Nakyesige 3, Philippa Musoke 1, Kirsty Le Doare 1,2
Editor: Ting Shi4
PMCID: PMC10707482  PMID: 38064420

Abstract

Kawempe National Referral Hospital (KNRH) is a tertiary facility with over 21,000 pregnant or postpartum women admitted annually. The hospital, located in Kampala, Uganda, uses an Electronic Medical Records (EMR) system to capture patient data. Used since 2017, this readily available electronic health record (EHR) has the benefit of informing real-time clinical care, especially during pandemics such as COVID-19. We investigated the use of EHR to assess risk factors for adverse pregnancy and infant outcomes that can be incorporated into a data visualization dashboard for real time decision making during pandemics. This study analysed data from the UgandaEMR collected at pre-, during- and post-lockdown timepoints of the COVID-19 pandemic to determine its use in monitoring risk factors for adverse pregnancy and neonatal outcomes. Logistic regression models were used to identify the risk factors for adverse pregnancy and maternal outcomes including prematurity, obstetric complications, still births and neonatal deaths. Pearson chi-square test was used for pair-wise comparison of the outcomes at the various stages of the pandemic. Data analysis was performed in R, within the International COVID-19 Data Alliance (ICODA) workbench. A visualisation dashboard was developed based on the risk factors, to support decision making and improved healthcare delivery. Comparison of pre-and post-lockdown variables showed an increased risk of pre-term birth (adjusted Odds Ratio (aOR = 1.67, 95% confidence interval (CI) 1.38–2.01)); obstetric complications (aOR = 2.77, 95% CI: 2.53–3.03); immediate neonatal death (aOR = 3.89, 95% CI 2.65–5.72) and Caesarean section (aOR = 1.22, 95% CI 1.11–1.34). The significant risk factors for adverse outcomes were younger maternal age and gestational age <32weeks at labour. This study demonstrates the feasibility of using EHR to identify and monitor at-risk subpopulation groups accessing health services in real time. This information is critical for the development of timely and appropriate interventions in outbreaks and pandemic situations.

Introduction

The direct effects of COVID-19 can be measured by the number of cases and associated morbidity and mortality data. However, changes in health service delivery or utilization secondary to lockdown restrictions will also impact upon the health and wellbeing of the population indirectly. Data from early in the pandemic showed the negative impact of lockdown restrictions on maternal and neonatal health, with an increase seen in pregnancy complications such as stillbirth and preterm birth, increase in admissions to neonatal intensive care units and neonatal deaths, as well as decreased frequency of routine vaccination for infants [1]. Availability of accurate, timely and reliable data for monitoring the risk factors for these negative outcomes is therefore critical for improving the safety and well-being of both mother and child, especially during periods of health care disruption caused by pandemics.

Electronic Health Records (EHRs) are becoming widely available in Uganda and other low resource settings and have reduced the cost of capturing and storing patient data compared to traditional paper-based tools; improved tracking of patients and clinic efficiency secondary to availability of patient data [2]. When combined with dashboards to present summary data, including user defined interfaces and reports, such large datasets can be used by healthcare workers and facility managers for planning and monitoring purposes [3]. Uganda first piloted and adopted an open-source electronic medical records system, the UgandaEMR, in 2011, now in use in more than 1000 health facilities across the country [4]. The system enables unique identification and tracking of patients throughout their hospital attendances and reporting & sharing of data across departments (e.g., Pharmacy, Laboratory, Clinic). The system is also linked to the national District Health Information System (DHIS2) and therefore facilitates direct reporting on key health services performance indicators. Development partners such as UNAIDS, WHO and UNICEF have supported use of EHRs to monitor service delivery and inform improvement in healthcare delivery decisions in Uganda [5–7]. The Ministry of Health and these development partners have also invested in improving the quality of data from these systems through monthly and quarterly monitoring and reviews, capacity building and strengthening of infrastructures to support electronic data capture and management at health facility level [2].

Our primary hypothesis was that EHR could be used to identify risk factors for adverse pregnancy and infant outcomes during pandemics such as COVID-19 to inform real-time clinical care decisions. We aimed to investigate changes in risk factors in three discrete time periods: pre-, during- and post-pandemic lockdown using routine EHR. We also sought to incorporate these risk factors for adverse pregnancy and infant outcomes in a user-friendly dashboard interface that could be utilised by both the local health facility and Ministry of Health to monitor and predict adverse health outcomes and introduce risk mitigation measures in real time during this and future outbreaks and pandemics.

Methods

Data and setting

Kawempe National Referral Hospital (KNRH) is a tertiary women and children’s hospital based in Kampala, Uganda. It is a high-volume health facility with over 21,000 deliveries, 40,000 antenatal attendances, 45,000 PMTCT attendances and 28,000 BCG vaccination clinic visits. The Hospital uses UgandaEMR to capture information on all individuals (men, women and children) accessing healthcare services at the facility. The UgandaEMR is installed on a central server at Kawempe National Referral Hospital and accessible through a web browser. The system captures data for antenatal, delivery and postnatal attendance at the hospital. Health care workers write patient information on paper tools, based national Health Management Information System (HMIS), supplied by Ministry of Health, Uganda. The information is then transcribed into the electronic information system by records clerks. The system has inbuilt data quality and integrity checks, as well as customized reports for Ministry of Health reporting. Each user has a unique username and password. The development and maintenance of the system is supported by the Makerere University Monitoring and Evaluation Technical Support project (METS) funded by President’s Emergency Plan for AIDS Relief (PEPFAR)-USA through the Centers for Diseases Control (CDC), Uganda. The research techniques adhere to the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) Statement [8].

We analyzed data from the hospital antenatal, maternal and neonatal attendance for the period January 2020 to October 2021. The variables included in the analysis were maternal age (defined as <20, 20–24, 25–34 or 35+ years), gravidity (primigravida, multi-gravida (<5 pregnancies)-low or multigravida (> = 5 pregnancies -High), parity (nullipara, primipara or multipara), obstetric diagnosis—the clinician evaluation of the mode of delivery (born before arrival, caesarian section or spontaneous vaginal delivery), obstetric complications defined as a mother experiencing any complications before or at the time of admission to labour or in the peripartum period requiring an intervention -yes or no; these complications included e.g. pre-eclampsia, antenatal or postnatal hemorrhage and malaria in pregnancy etc. and these were all combined as composite variable), gestational age at time of hospital admission or at onset of labour (<28, 28–32 or 35+ weeks) and maternal status at discharge (alive or dead). Infant data included birth weight (<1.5, 1.5–2.4 or 2.5+ Kilograms), APGAR score at 1 and 5 minutes (0, 1–6 or 7+), condition of infant at birth (live birth, Immediate neonatal death or still birth) and whether the infant was born prematurely/delivery outcome (Pre-term and term).

The study used cross-sectional panel data collected and categorized as Pre-lockdown (1st January–17 March 2020), Lock down (18 March 2020 to 25th May 2020 and 7th June 2021 to 31st July 2021) and Post Lockdown: 26th May 2020 to 6th June 2020 and 1st August 2021 to 31st Oct 2021). During these periods, the country experienced varying levels of Government restrictions/containment measures to avert the spread of COVID-19 (S1 Table).

Statistical analysis

Descriptive statistics on maternal characteristics, and outcome of mother and infant during antenatal attendance, admission to labor and at discharge were summarized and reported. Means and standard deviations were reported for continuous variables and where the data was not normally distributed, medians and interquartile range were reported. Frequencies and percentages were computed and reported for categorical variables. Chi square and median tests were used for the pairwise comparison of outcomes for the pre- versus during and post COVID-19 lockdown time points for the categorical and continuous variables respectively. Results are presented, comparing outcomes for the period pre-lockdown versus lockdown and the period pre-lockdown versus the post lockdown period separately. We also present, graphically antenatal and delivery attendance volumes over the period of analysis.

Multinomial regression models were used to calculate prevalence (odds) ratios for adverse pregnancy and maternal outcomes for the period before COVID-19 lockdown (pre-lockdown), during the COVID-19 lock down (lockdown) and immediately post-lockdown period. Binary logistic regression model was used to assess the risk factors for adverse delivery outcome (pre-term births) and whether mother had an obstetric complication while multinomial logistic regression was applied to ascertain the risk factors for still birth, immediate neonatal death, likelihood of caesarean section and for children born before arrival to hospital. All the models were adjusted for COVID-19 lockdown phases (pre-, during and post- lockdown). Crude and Adjusted Odds ratios were computed after controlling for age, parity, gravidity and gestational age. Data analysis was carried out in R, within the ICODA workbench (Aridhia) [9]. The workbench provided pre-developed and well tested statistical tools and models for statistical analysis and presentation of the analysis results.

Data used for this study is routine service delivery data and therefore had a high level of missingness. Variables considered for the analysis were those with less than 30% missingness overall, irrespective of the period this occurred. S2 Table presents the level of missingness and the statistical models applied to impute for missing data for each variable considered in the analysis. Multiple Imputation via Chained Equations (MICE) was used to impute missing values, because it allows for application of specific and suitable models based on the distribution of the observed values of the variable (outcome) of interest.

Methodology—Dashboard development

To comprehensively develop the dashboard, we solicited stakeholder input through consultative meetings with officials from Ministry of Health and KNRH. During the stakeholder meetings, data on the level of completeness, consistency and validity were shared and strategies to improve the quality of data collected and entered into the system were sought. Further consultations in the form of one-to-one meetings, presentations and chart review were conducted to refine the strategies developed and the outlay of the dashboard. Microsoft Power BI Desktop version 2.104.702.0, and the UgandaEMR system were integrated using SQL connector. Anonymised data from the different tables in the UgandaEMR database were extracted using SQL queries. Data analysis expressions were then written in Power BI to collate data relating to the risk factors identified during risk factor modelling and summaries are presented on the dashboard with dynamic filters for days, weeks, months, and years as may be desired by users. Fig 1 presents a sample of the dashboard interface.

Fig 1. Sample dashboard layout showing ANC and labour attendance and outcomes for both mother and infant.

Fig 1

A summary dashboard page showing antenatal attendance, labour and delivery outcomes for the period 1st April 2022 to 30th April 2022.

Ethics statement

Ethical clearance to conduct this study was obtained from the Makerere University School of Medicine Research Ethics Committee SOMREC (#2020–089), Uganda National Council of Science and Technology (#HS623S) and St George’s School of Medicine Research Ethics Committee (#2020.0146). All individual-level data was identified using unique person identifiers only, names and other personally identifiable information were excluded.

Consent

Data were extracted from an anonymous Ministry of Health data records system. Healthcare providers seek verbal consent from all women to before recording their information on the paper forms and thereafter provide the needed healthcare (antenatal, delivery and postnatal care services). For neonates, written informed consent is provided by parent(s)/guardian. If a mother died during the course of health care access and the infant’s father had not given consent, then the infant’s guardian was asked to provide informed consent for the continued provision of care to the baby. Information about services available in the hospital and possible choices is provided during a general health talk to all women and their caregivers every morning before service delivery commence.

Results

Between January 1st 2020 and October 31st, 2021 there were 15,870 first ANC attendances, 41,287 deliveries, and 42,870 post-natal attendances. Over 45,000 women were tested for HIV. The median number of monthly deliveries was 1,905 (IQR: 1,823–1,976). Figs 2 and 3 present the monthly total antenatal attendances and deliveries in the hospital for the period January 2020 to October 2021. Figs 2 and 3 presents service volumes over the period of the study.

Fig 2. Total antenatal attendance: Jan 2020 to Oct 2021.

Fig 2

Fig 2 shows monthly total ANC attendance for the period January 2020 to October 2021 at KNRH. Vertical dotted lines indicate timepoints (months) when total lockdown was in place.

Fig 3. Total number of deliveries: Jan 2020 to Oct 2021.

Fig 3

Fig 3 shows monthly total deliveries for the period January 2020 to October 2021 at KNRH. Vertical dotted lines indicate timepoints (months) when total lockdown was in place.

Maternal and infant characteristics

Most of the women were aged 25-34years (2,514 (43.1%) pre-, 3,824 (44.9%) during- and 5,904 (43.6%) post-lockdown; most of the women were multipara (2,081 (35.7%) pre-, 3,081 (36.2%) during- and 5,154 (37.0%) post-lockdown). Maternal and infant characteristics can be seen in Table 1.

Table 1. Maternal and baby characteristics and outcomes.

Characteristic Pre-Lockdown (n = 5,833) Lockdown (n = 8,519) Post-Lockdown (n = 13,544) P1 P2
Maternal Age (Years)
<20 773 (13.3) 984 (11.6) 1,661 (12.3) 0.013 0.118
20–24 2,050 (35.2) 2,984 (35.0) 4,730 (34.9)
25–34 2,514 (43.1) 3,824 (44.9) 5,904 (43.6)
35+ 494 (8.5) 726 (8.5) 1,246 (9.2)
(Missing = 6)
Parity
Nullipara 1,855 (34.5) 2,640 (34.2) 4,193 (33.2) 0.380 0.039
Primipara 1,435 (26.7) 2,003 (25.9) 3,301 (26.1)
Multipara 2,081 (38.8) 3,081 (39.0) 5,154 (40.8)
(Missing = 2152)
Gravidity
Primigravida 1,725 (33.9) 2,524 (33.9) 4,088 (34.0) 0.809 0.857
Multigravida-Low 2,685 (52.8) 3,908 (52.4) 6,296 (52.4)
Multigravida-High 678 (13.3) 1,020 (13.7) 1,638 (13.6)
(Missing = 3331)
Gestational age (Weeks),
Pre-term (<28 weeks) 71 (1.4) 93 (1.3) 156 (1.5) 0.195 0.127
Pre-term (28–32 weeks) 92 (1.9) 166 (2.3) 255 (2.4)
Term (>32 weeks) 4,795 (96.7) 6,938 (96.4) 10,365 (96.2)
(Missing = 2,197)

P1 -P value for Chi-square test comparison between Pre- Lockdown and Lockdown time period, P2- P value for Chi-square test comparison between Pre-Lockdown and Post Lockdown time period

Impact of COIVD-19 lockdown and risk factors for adverse pregnancy and infant outcomes

Maternal and neonatal outcomes at the different time points (pre-lock down, lockdown and post-lockdown) are presented in Table 2 and the risk factors for adverse pregnancy outcomes are presented in Table 3.

Table 2. Maternal and infant outcomes comparing pre-lockdown, lockdown and post-lockdown time periods.

a) Pre-Lockdown Vs Lockdown b) Pre-Lock Vs Post lock down
Characteristics cOR* (95% CI) aOR** (95% CI) cOR (95% CI) aOR (95% CI)
Birth Weight of Baby (Kgs)
<1.5 1.00 (0.84–1.20) 0.85 (0.67–1.07) 1.04 (0.89–1.22) 0.89 (0.72–1.11)
1.5–2.4 1.01 (0.91–1.12) 0.96 (0.85–1.08) 1.01 (0.92–1.11) 0.95 (0.86–1.05)
2.5+ 1.00 1.00 1.00 1.00
Apgar Score (At 1 minute)
0 1.10 (0.92–1.33) 1.05 (0.88–1.27) 1.17 (1.00–1.38) 1.13 (0.96–1.32)
1–6 0.98 (0.88–1.08) 0.96 (0.86–1.07) 1.09 (0.97–1.23) 1.07 (0.94–1.22)
7+ 1.00 1.00 1.00 1.00
Apgar Score (at 5 Minutes)
0 1.13 (0.95–1.35) 1.09 (0.92–1.29) 1.19 (1.02–1.39) 1.15 (0.98–1.34)
1–6 1.06 (0.90–1.25) 1.05 (0.76–1.24) 1.24 (1.07–1.44) 1.22 (1.05–1.42)
7+ 1.00 1.00 1.00 1.00
Delivery Outcome
Pre-term 1.34 (1.20–1.49) 1.35 (1.18–1.56) 1.52 (1.37–1.68) 1.67 (1.38–2.01)
Term 1.00 1.00 1.00 1.00
Condition of baby at discharge
Live Birth 1.00 1.00 1.00 1.00
Still Birth 1.05 (0.90–1.23) 1.01 (0.87–1.18) 1.06 (0.92–1.23) 1.03 (0.90–1.19)
Immediate neonatal death 3.04 (2.02–4.57) 2.96 (1.95–4.48) 4.02 (2.75–5.88) 3.89 (2.65–5.72)
Obstetric Diagnosis
Born Before Arrival 1.10 (0.97–1.25) 1.09 (0.95–1.26) 0.42 (0.36–0.49) 0.38 (0.31–0.45)
Cesarean Section 1.12 (1.03–1.21) 1.12 (1.02–1.21) 1.21 (1.10–1.33) 1.22 (1.11–1.34)
SVD 1.00 1.00 1.00 1.00
Obstetric Complication
No 1.00 1.00 1.00 1.00
Yes 2.63 (2.39–2.90) 2.62 (2.38–2.88) 2.78 (2.54–3.05) 2.77 (2.53–3.03)

*Crude Odds Ratio

** Adjusted Odds Ratio

a) Pre-Lockdown Vs Lockdown is the comparison between pre-lockdown and lockdown time points;

b) Pre-Lock Vs Post lock down is the comparison between pre-lockdown and post lock lockdown time point; cOR-crude Odds Ratio; aOR- adjusted Odds Ratios for the outcomes, controlling for Mothers’ Age, Gravidity, Parity and gestational age at admission.

Table 3. Risk factors for selected adverse pregnancy outcomes.

M1:Delivery Outcome (Preterm) aOR (95% CI) M2: Obstetric complication (Yes) aOR (95% CI) M3:Still Birth aOR (95% CI) M3: Immediate Neonatal death aOR (95% CI) M4: Caesarian Section aOR (95% CI) M5: Born Before Arrival aOR (95% CI)
Mothers Age (Years)
<20 1.26 (1.14–1.40) 0.97 (0.90–1.05) 0.84 (0.72–0.99) 1.37 (1.06–1.77) 0.66 (0.61–0.71) 2.48 (1.96–3.15)
20–24 1.08 (1.01–1.17) 0.99 (0.94–1.04) 0.93 (0.83–1.05) 1.19 (1.02–1.39) 0.86 (0.82–0.91) 1.80 (1.59–2.03)
25–34 1.00 1.00 1.00 1.00 1.00 1.00
35+ 1.06 (0.93–1.20) 1.06 (0.98–1.15) 1.25 (1.08–1.44) 0.95 (0.75–1.20) 1.05 (0.96–1.14) 0.66 (0.55–0.79)
Parity
Nullipara 1.00 1.00 1.00 1.00 1.00 1.00
Primipara 0.97 (0.84–1.13) 0.94 (0.85–1.05) 0.78 (0.63–0.95) 1.05 (0.76–1.46) 0.93 (0.84–1.02) 17.8 (13.83–22.92)
Multipara 1.05 (0.89–1.24) 0.93 (0.82–1.04) 0.83 (0.67–1.03) 1.14 (0.77–1.69) 0.92 (0.83–1.01) 26.6 (19.39–36.37)
Gravidity
Primigravida 1.00 1.00 1.00 1.00 1.00 1.00
Multigravida-Low 1.08 (0.93–1.25) 1.01 (0.90–1.13) 1.30 (1.07–1.58) 1.22 (0.85–1.78) 1.12 (1.02–1.23) 0.19 (0.12–0.28)
Multigravida-High 1.27 (1.05–1.55) 1.02 (0.89–1.18) 1.54 (1.22–1.94) 1.38 (0.91–2.10) 0.94 (0.84–1.05) 0.16 (0.09–0.30)
Gestational age (Weeks)
Pre-term (<28 weeks) 1.42 (1.19–1.69) 6.05 (4.53–8.08) 14.91 (10.19–21.81) 0.42 (0.31–0.55) 11.08 (3.60–34.03)
Pre-term (28–32 weeks) 1.38 (1.26–1.51) 4.12 (3.57–4.74) 6.18 (4.88–7.83) 0.65 (0.58–0.72) 4.56 (2.96–7.04)
Term (>32 weeks) 1.00 1.00 1.00 1.00 1.00
Time-period
Pre-Lockdown 1.00 1.00 1.00 1.00 1.00 1.00
Lock Down (period) 1.35 (1.18–1.56) 2.62 (2.38–2.88) 1.01 (0.87–1.18) 2.93 (1.93–4.46) 1.11 (1.02–1.21) 1.08 (0.94–1.24)
Post Lock down 1.66 (1.38–2.00) 2.77 (2.53–3.03) 1.03 (0.89–1.18) 3.93 (2.66–2.80) 1.22 (1.11–1.34) 0.35 (0.29–0.42)

aOR- adjusted Odds Ratio; M1, M2 and M5- Binary logistic regression models while M3 &M4: Multinomial logistic regression models and used.

Gestational age excluded from M1 because they were highly correlated

Prematurity

The odds of delivering a premature infant increased during the lockdown and post-lockdown periods compared to the period before the lockdown (adjusted Odds Ratio (aOR) = 1.35(95% confidence interval (CI): 1.18–1.56) and (aOR = 1.67 (95% CI: 1.38–2.01) respectively (Table 2).

The odds of preterm birth were highest in younger mothers (age<20, aOR = 1.26: 1.14–1.40) compared to mothers aged 25–34 years. Odds of pre-term births were higher in the age group 35+ years compared to those aged 25-34years, although not statistically significant. Other risk factors associated with prematurity included having >5 previous pregnancies (aOR 1.27, 1.05–1.55) compared to Primigravida. The odds of prematurity were highest in the post-lockdown period (aOR 1.66, 1.38–2.00) compared to the period before the outbreak of COVID-19 (Table 3).

Obstetric complications

Maternal complications increased during and after lockdown. The odds of maternal complication were highest in periods of post-lockdown (aOR = 2.77, 95% CI: 2.53–3.03) compared to the period pre-lockdown. The likelihood of Obstetric complication was also higher during the lockdown period compared to the period before the lockdown (aOR = 2.62, 95% CI 2.38–2.88) (Table 2).

The odds of obstetric complications were highest among women who gave birth at gestation <28 weeks and 28-32weeks compared to those who gave birth at gestation >32weeks (aOR = 1.42: 95% CI 1.19–1.69; and aOR = 1.38, 95% CI: 1.26–1.51 respectively) (Table 3).

Still-births and immediate neonatal deaths

Whilst there was no statistically significant increase in the odds of stillbirth during lockdown and post-lockdown compared to pre-lockdown period, the odds of immediate neonatal deaths increased significantly during lockdown and post-lockdown timepoint compared to the pre-lockdown period (aOR = 2.96, 95% CI: 1.95–4.48) and aOR = 3.89, 95% CI: 2.65–5.72) respectively (Table 2).

The odds of immediate neonatal death was significantly higher in younger mothers aged <20 years (aOR 1.37, 95%CI: 1.06–1.77) and mothers aged 20–24 years compared to those aged 25–34 years. Immediate neonatal death was lower but not statistically significant among those aged 35+ years compared to those aged 25-34years. Women who delivered infants at <28 weeks of gestation (aOR 14.91, 10.19–21.81) or between 28–32 weeks of gestation (aOR 6.18, 4.88–7.83) compared to those who delivered infants at >32 weeks of gestations were also more likely to deliver infants who die immediately after birth (Table 3).

Additionally, the odds of stillbirths were higher in mothers over the age of 35 years (aOR = 1.25, 95% CI: 1.08–1.44) and in mothers who with >5 previous preganncies (AOR = 1.54, 95% CI: 1,22–1.94) compared to mothers aged 25–34 years and those who were Primigravida respectively. The odds of stillbirth were also higher in those born at lower gestational age (i.e. aOR = 6.05, 95% CI: 4.53–8.08) and aOR = 4.12, 95% CI: 3.57–4.74) for <28 weeks and 28–32 weeks respectively compared those born at gestational age >32 weeks.

Obstetric diagnosis

The odds of caesarian section was significantly higher during and after the lock-down compared to the time period pre-lockdown (aOR = 1.12, 95% CI: 1.02–1.21) and aOR = 1.22, 95% CI: 1.11–1.34) respectively), while the odds of infants being born before arrival to the health facility post the lockdown period decreased compared to the period pre-lockdown (aOR = 0.38, 95% CI: 0.31–0.45) (Table 2).

The odds of caesarian section was significantly lower in younger mothers (age<20 years, aOR = 0.66, 95% CI: 0.61–0.71) and those aged 20–24 years aOR = 0.86, 95% CI: 0.82–0.91) compared to mothers aged 25–34 years. The odds of undergoing caesarian section was also significantly lower among women who delivered at gestation age <28 weeks and 28–32 weeks compared to those who delivered at gestation age >32weeks (aOR = 0.42, 95% CI: 0.31–0.55 and aOR = 0.65, 95% CI 0.58–0.72 respectively) (Table 3).

Discussion

Our study shows that it is feasible to use EHR to identify and monitor at risk subpopulation groups accessing health services during times of extreme service pressure such as outbreaks and pandemics.

Infants born preterm have higher morbidity and mortality than those born at term, with preterm birth being a leading cause of infant mortality globally [10]. Changes in preterm birth rates were reported following lockdown measures, with estimates fluctuating between -90% to +30% change in risk [11]. Reductions were described generally in high-income settings [12–15], with the inverse being reported in low some low-income settings [11, 16]. Reports of rates of stillbirth were also mixed [11, 17]. Our study shows an increased risk of preterm birth in lockdown and post-lockdown periods in our setting and adds to the global body of evidence, though we acknowledge that missing data may limit interpretability.

We also report an increase in maternal complications and immediate neonatal death in lockdown and post-lockdown time periods. A systematic review undertaken in 2021 highlighted worsening maternal and neonatal outcomes during the pandemic, with inequity noted between high and low income settings [17]. Previous research from Uganda similarly showed an increase rate of maternal complications in the first wave of the pandemic [1], and this study confirms these findings in subsequent waves. Data from Zimbabwe showed a more resilient maternity services [18] suggesting that health care services and policy makers in low-resource settings can implement restrictive public health measures in a way which does not inadvertently harm pregnant women and children. Dialogue between institutions and agencies and across countries should be undertaken in parallel to interventions to highlight areas of good practice and share knowledge.

The direct effects of SARS-CoV-2 should also be considered. A multinational cohort study of 2,130 pregnant women across 18 countries, including Ghana and Nigeria, suggested that women with symptomatic COVID-19 during pregnancy had an increased risk of morbidity and mortality compared to non-infected pregnant women, including maternal mortality, pre-term birth and pre-eclampsia [19], though other evidence from Africa has been mixed [20]. In Uganda, the Ministry of Health did not utilise KNRH as a COVID-19 treatment facility, and pregnant women who were suspected to be SARS-CoV-2 positive were moved to another hospital for treatment. It is unlikely, therefore, that the increased rate of prematurity and neonatal mortality in the lock-down period can be attributed solely to symptomatic or severe maternal infection with SARS-CoV-2. It is possible that delays in seeking antenatal and delivery care, worsened by periods of significant restrictions in public transport and a fear of acquiring COVID-19 in hospital, led to these outcomes.

Using our data, we were able to identify specific at-risk groups within the pregnant population such as younger women and those with multiple pregnancies or those admitted for labour at gestational age<32 weeks that are especially vulnerable to health services disruption [21].

Using EHR, we were able to demonstrate that, in Uganda, these changes were sustained post the easing of lock down restrictions and may suggest that the socioeconomic impact of COVID-19 had longer term indirect adverse health outcomes after the pandemic eased. Studies from Uganda have described increased food insecurity secondary to the pandemic [22]. Women, who have higher rates of unemployment and jobs that are more vulnerable to COVID-19 restrictions, were also the first to stop working during the COVID-19 pandemic [23]. This, coupled with decreased access to antenatal care during the strictest of lockdown periods [1], may have meant that women reported late to hospital and thus had an increased risk of complications during their pregnancies. This is useful information for public health bodies, seeking to target specific groups and maintain vital services during and after lockdown restrictions. We have recently reported the effect of a more localised lockdown during the Ebola outbreak in Uganda on women’s health services [24].

The results of our analysis have informed development of a risk factor model and interactive dashboard for use by MOH and KNRH management to monitor changes in service use and early indicators of health system stressors. The development of a dashboard was key to disseminating the results of our study and utilized an interactive open forum comprised of teams from MOH and KNRH with expertise in MNCH services and service delivery. Engagement meetings were important prior to the development of the dashboard as they enabled critical data elements of importance nationally to be selected from the routine service delivery database systems to ease analysis and use of the data to improve service delivery. Going forward stakeholder preferences will be key for tracking pregnancies and ensuring that the data associated with key outcomes is robust and of high quality. Electronic health records can be utilised to rapidly synthesise data in periods of rapid policy intervention to assess indirect effects and should be considered as a key tool for health monitoring. Use of EHR data to create real-time and interactive dashboards for individual facilities can increase awareness of health managers and policy makers to the impact of policy changes and alert health care workers to vulnerable patient groups.

We are limited by the use of retrospective data from a single site. KNRH is in a busy, urban area, and patterns emerging from this site may not be reflected in other health care facilities in other parts of Uganda. The use of EHR as a data source relies on health care professionals completing data capture promptly and accurately at the time of a health care encounter. Missing data, as seen in our study, requires careful consideration when interpreting trends in health outcomes. We note missing data by lockdown period and have document missing data overall due to inability to extrapolate further. The impact of missing data on inferential power of this study given the high level of missingness in routine data should be considered as the system is rolled out. Other limitations include the unavailability of important risk factors such as pre-existing diabetes mellitus, hypertension, cardiovascular diseases which are important risk factors for COVID-19 disease as well as for adverse maternal and neonatal outcomes in general. However, we minimised the impact of missing data by using MICE to impute for missing data from our large dataset.

Important areas for further research include reviewing data from wider geographical settings including rural and urban areas to assess the impact of COVID-19 interventions in these areas among Adolescent Girls and Young Women (AGYW) and extending our approach to determine the impact of COVID-19 to other health areas.

Conclusion

The effects of the COVID-19 pandemic are wide ranging, with the disruption to antenatal and maternal health care services highlighting the susceptibility of these healthcare services to wider global events. There is an urgent need for healthcare systems to plan for future pandemics or periods of insecurity in a way which limits indirect harm to vulnerable populations. Use of EHR and easy to use dashboards may enable healthcare providers and policy makers to rapidly identify at risk populations and consider health care interventions to improve health outcomes in this and future outbreaks and pandemics.

Supporting information

S1 Table. Level of Government restrictions on the spread of COVID-19.

(PDF)

S2 Table. Missing data pattern and model used.

(PDF)

Acknowledgments

We thank Edinance Basirika, Emily Namara Lugoloobi for supporting implementation of UgandaEMR at Kawempe National Referral Hospital. We thank the Records team led by Edirisa Muwanga and Allan Mugabi, the administration and all other staff of Kawempe National Referral Hospital for all their support and guidance as we conducted the study. We further thank Ministry of Health Uganda leadership, the technical teams from Ministry of health and the administration of Makerere University Johns Hopkins University Research Collaboration for all their contributions, logistical and all other support rendered.

Abbreviations

ICODA

International COVID-19 Data Alliance

IROC

Incidence and Risk Factors for COVID-19 amongst Pregnant and Lactating Women and their Infants in Uganda

KNRH

Kawempe National Referral Hospital

Data Availability

Data are available in a public, open access repository (Figshare) at St George's University, London. The link to the dataset is DOI: 10.24376/rd.sgul.22116965.

Funding Statement

This study was funded through the Grand Challenges ICODA pilot initiative, delivered by Health Data Research UK by the Bill & Melinda Gates Foundation and the Minderoo Foundation to KLD. Research reported in this publication was also supported by the National Institutes of Health’s Fogarty International Center’s Training award number D43TW012275 to KLD. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Health Data Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Burt JF, Ouma J, Lubyayi L, Amone A, Aol L, Sekikubo M, et al. Indirect effects of COVID-19 on maternal, neonatal, child, sexual and reproductive health services in Kampala, Uganda. BMJ Global Health. 2021;6(8):e006102. doi: 10.1136/bmjgh-2021-006102 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Kiberu VM, Matovu JK, Makumbi F, Kyozira C, Mukooyo E, Wanyenze RK. Strengthening district-based health reporting through the district health management information software system: the Ugandan experience. BMC Med Inform Decis Mak. 2014;14:40. doi: 10.1186/1472-6947-14-40 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Brown DS, Aydin CE, Donaldson N. Quartile dashboards: translating large data sets into performance improvement priorities. J Healthc Qual. 2008;30(6):18–30. doi: 10.1111/j.1945-1474.2008.tb01166.x [DOI] [PubMed] [Google Scholar]
  • 4.Ministry of Health U. Uganda National eHealth Policy Ministry of Health 2016.
  • 5.Chan M, Kazatchkine M, Lob-Levyt J, Obaid T, Schweizer J, Sidibe M, et al. Meeting the demand for results and accountability: a call for action on health data from eight global health agencies. PLoS Medicine. 2010;7(1):e1000223. doi: 10.1371/journal.pmed.1000223 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Rice B, Boulle A, Baral S, Egger M, Mee P, Fearon E, et al. Strengthening routine data systems to track the HIV epidemic and guide the response in sub-Saharan Africa. JMIR public health and surveillance. 2018;4(2):e9344. doi: 10.2196/publichealth.9344 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Sheng B, Marsh K, Slavkovic AB, Gregson S, Eaton JW, Bao L. Statistical models for incorporating data from routine HIV testing of pregnant women at antenatal clinics into HIV/AIDS epidemic estimates. AIDS (London, England). 2017;31(Suppl 1):S87. doi: 10.1097/QAD.0000000000001428 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495–9. doi: 10.1016/j.ijsu.2014.07.013 [DOI] [PubMed] [Google Scholar]
  • 9.Ross-Davie M, Brodrick A, Randall W, Kerrigan A, McSherry M. 2. Labour and birth. Best Practice and Research: Clinical Obstetrics and Gynaecology. 2021;73:91–103. doi: 10.1016/j.bpobgyn.2021.03.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Vogel JP, Chawanpaiboon S, Moller A-B, Watananirun K, Bonet M, Lumbiganon P. The global epidemiology of preterm birth. Best Practice & Research Clinical Obstetrics & Gynaecology. 2018;52:3–12. [DOI] [PubMed] [Google Scholar]
  • 11.Calvert C, Brockway M, Zoega H, Miller JE, Been JV, Amegah AK, et al. Changes in preterm birth and stillbirth during COVID-19 lockdowns in 26 countries. Nature human behaviour. 2023;7(4):529–44. doi: 10.1038/s41562-023-01522-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Matheson A, McGannon CJ, Malhotra A, Palmer KR, Stewart AE, Wallace EM, et al. Prematurity rates during the coronavirus disease 2019 (COVID-19) pandemic lockdown in Melbourne, Australia. Obstetrics and gynecology. 2021;137(3):405. doi: 10.1097/AOG.0000000000004236 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Gallo LA, Gallo TF, Borg DJ, Moritz KM, Clifton VL, Kumar S. A decline in planned, but not spontaneous, preterm birth rates in a large Australian tertiary maternity centre during COVID‐19 mitigation measures. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2022;62(1):62–70. doi: 10.1111/ajo.13406 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Justman N, Shahak G, Gutzeit O, Ben Zvi D, Ginsberg Y, Solt I, et al. Lockdown with a price: the impact of the COVID-19 pandemic on prenatal care and perinatal outcomes in a tertiary care center. Isr Med Assoc J. 2020:533–7. [PubMed] [Google Scholar]
  • 15.Hedermann G, Hedley PL, Bækvad-Hansen M, Hjalgrim H, Rostgaard K, Poorisrisak P, et al. Danish premature birth rates during the COVID-19 lockdown. Archives of Disease in Childhood-Fetal and Neonatal Edition. 2021;106(1):93–5. doi: 10.1136/archdischild-2020-319990 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Kc A, Gurung R, Kinney M, Sunny A, Moinuddin M, Basnet O, et al. Effect of the COVID-19 pandemic response on intrapartum care, stillbirth, and neonatal mortality outcomes in Nepal: a prospective observational study. Lancet Glob Health 8 (10): e1273–e1281. 2020. doi: 10.1016/S2214-109X(20)30345-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Chmielewska B, Barratt I, Townsend R, Kalafat E, van der Meulen J, Gurol-Urganci I, et al. Effects of the COVID-19 pandemic on maternal and perinatal outcomes: a systematic review and meta-analysis. The Lancet Global Health. 2021;9(6):e759–e72. doi: 10.1016/S2214-109X(21)00079-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Shakespeare C, Dube H, Moyo S, Ngwenya S. Resilience and vulnerability of maternity services in Zimbabwe: a comparative analysis of the effect of Covid-19 and lockdown control measures on maternal and perinatal outcomes, a single-centre cross-sectional study at Mpilo Central Hospital. BMC Pregnancy and Childbirth. 2021;21(1):416. doi: 10.1186/s12884-021-03884-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Villar J, Ariff S, Gunier RB, Thiruvengadam R, Rauch S, Kholin A, et al. Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: the INTERCOVID multinational cohort study. JAMA pediatrics. 2021;175(8):817–26. doi: 10.1001/jamapediatrics.2021.1050 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Nachega JB, Sam-Agudu NA, Machekano RN, Rosenthal PJ, Schell S, de Waard L, et al. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Pregnancy in Sub-Saharan Africa: A 6-Country Retrospective Cohort Analysis. Clinical Infectious Diseases. 2022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Cavazos-Rehg PA, Krauss MJ, Spitznagel EL, Bommarito K, Madden T, Olsen MA, et al. Maternal age and risk of labor and delivery complications. Maternal and child health journal. 2015;19:1202–11. doi: 10.1007/s10995-014-1624-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Kansiime MK, Tambo JA, Mugambi I, Bundi M, Kara A, Owuor C. COVID-19 implications on household income and food security in Kenya and Uganda: Findings from a rapid assessment. World Development. 2021;137:105199. doi: 10.1016/j.worlddev.2020.105199 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.World Bank. 2020. COVID-19 Impact Monitoring: Uganda Round 3. © World Bank, Washington, DC. http://hdl.handle.net/10986/34993 License: CC BY 3.0 IGO.
  • 24.Chowdhury M, Ouma J, Nakabembe E, Mwanga-Amumpaire J, Kirenga B, Bosa HK, et al. Strengthening the maternal and child health responses to Ebola outbreaks in Uganda. The Lancet Infectious Diseases. 2023;23(6):650–1. doi: 10.1016/S1473-3099(23)00269-4 [DOI] [PubMed] [Google Scholar]
PLOS Glob Public Health. doi: 10.1371/journal.pgph.0002022.r001

Decision Letter 0

Hanna Landenmark

26 Jun 2023

PGPH-D-23-00246

Using routine data to understand adverse pregnancy and neonatal outcomes associated with the COVID-19 pandemic in Kampala, Uganda

PLOS Global Public Health

Dear Dr. Ouma,

Thank you for submitting your manuscript to PLOS Global Public Health. After careful consideration, we feel that it has merit but does not fully meet PLOS Global Public Health’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please see the comments from the reviewers below. Please pay particular attention to the concerns raised about clarifying the overall aim or aims of the manuscript - whether the focus is on the effectiveness of electronic records, or the COVID-19 pandemic, or both. Please ensure that this is clear to the reader from the outset - I leave it up to you to decide how you wish to frame the study, but please include all aims in the title, abstract and introduction.

Please submit your revised manuscript by Aug 07 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at globalpubhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgph/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Hanna Landenmark

Staff Editor

PLOS Global Public Health

Journal Requirements:

1. We ask that a manuscript source file is provided at Revision. Please upload your manuscript file as a .doc, .docx, .rtf or .tex.

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does this manuscript meet PLOS Global Public Health’s publication criteria? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

Reviewer #3: Partly

Reviewer #4: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: I don't know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: No

Reviewer #4: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS Global Public Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The aim of the research was to demonstrate the ability or capacity of the electronic health system to generate routine data that could be used to draw relationship between adverse outcomes for mothers and neonates and the COVID 19 pandemic.

Statistical analysis was well done and the data made available.

The manuscript was easy to read and presented in a well flowing manner.

No grammatical errors were identified and the language was plain with no ambiguity.

Reviewer #2: need to review the matter based on the clear research aim, in the adscript the research aim is linked with the situation of maternal health due to covid but in the conclusion parts link with effectiveness of electronic data capturing systems.

Data are well presented but its description is too less need to explain more

Conclusion and recommendation should be linked with the finding section.

Reviewer #3: The authors conducted an original study using EHR to determine maternal and neonatal outcomes during various stages of the COVID-19 pandemic (pre-lockdown, lockdown, post lockdown).

Specific comments:

Abstract:

-Can the author clarify the primary outcome in the abstract?

- Lines 38-40, authors reported the crude ORs for pre- versus lockdown not pre- versus post-lockdown of preterm and obstetric complications (Table 2). “Comparison of pre-and post-lockdown variables showed an increased risk of preterm birth (adjusted Odds Ratio (aOR) 1.34, 95% CI 1.20-1.49); obstetric complications (aOR 2.63, 95% CI 2.39-2.90)”

-What is meant obstetric complications?

Introduction:

-Can you provide the study hypothesis of the study

Methods:

-Lines 102-103, authors stated that “mode of delivery (defined as 1-born before arrival, 2-born by caesarian 103 section, or 3-born by spontaneous vaginal delivery)” what about aisted vafginal delivery? Were they removed from the analysis?

-Line 10 what is meant by obstetric complications, clarify this outcome refers to what exactly?

-How did the author specify whether the adverse outcomes were due the lockdown or pandemic itself? Are data available on COVID-19 for the mother? Was this consider in the analysis stage?

-Regarding missingness, there is a substantial amount of missing data on preterm delivery (52%) in the Pre-Lockdown stage, imputation might be not suitable for this variable.

-The authors might consider calculating the difference between the change in each outcome from the prelockdown to postlockdown periods

Results:

-I could not read data on Figure 1 & 2, may be consider increasing the resolution of them.

-Also Table S2 was not available with the submitted materials

-Lines 195-195 “There were higher proportion of children born at gestational age <32 weeks; higher

proportion of children with lower APGAR score (<7) at 1 and 5 minutes; higher proportions

women with obstetric complications; higher preterm births during and after COVID outbreak

compared to the period before COVID outbreak, Table 1”

I disagree with these interpretations, given the number of missingness on gestational age, APGAR score, you cannot confirm that there I high proportion of these outcome before after/during lockdown.

-Lines 197-198, ‘’ during and after COVID outbreak compared to the period before COVID outbreak” do you mean during and after COVID lockdown and before the lockdown period?

-Line199, correct COVI09 to COVID19

-More than 50% of data on preterm are missing in the pre-lockdown stage, were those with missingness excluded from the analysis in Table 2?

-Line 219 “The odds of preterm birth were highest in younger mothers (age<20, aOR 1.14-1.40)

compared to mothers aged 25-34 year” you write the CI, add the aOR=1.26.

_can the authors be consistent when reporting the finding, sometimes the lockdown period refers to as before the outbreak COVID 19.

-There are discrepancies between reported data in the text and that from the Table. In lines 245-247, “The odds of undergoing caesarian section were higher in younger mothers (age<20 years, aOR 2.48, 1.96-3.15 and those aged 20-24 years aOR 1.80, 1.59-2.03) compared to mothers aged 25-34 years while it was lower among older mothers aged 35+years (aOR: 0.66, 055-0.79).” author reported data related to born before arrival as data on CS (Table 3), correct these data in the text.

Discussion:

-The findings of the current study should be compared with that of the previous studies.

-The authors should highlight the limitations in the discussion, in particular, unavailable data on important risk factors, such as hypertensive disorder during pregnancy, DM covid-19 and.

-Also, the application and direction for further studies should be discussed

Other comments:

- The authors started with reference #7 in the introduction, what about reference from 1 to 6?

-References 11 & 12 are incomplete and irrelevant to the statements.

Reviewer #4: The manuscript evaluates the pregnancy outcomes pre, during, and post COVID-19 pandemic using electronic medical records. There are some major concerns that need to be addressed prior to reconsideration for publication.

- Suggest following the STROBE guidelines for observational studies

- Objective is not outlined. It is confusing to the reader if this study's primary objective is to demonstrate the use of electronic medical records or examine the pregnancy outcomes as affected by the pandemic.

- Study design is not presented in the methods section

- The variables need to be clearly defined (i.e., how is obstetric complication defined?)

- Any abbreviation should be defined initially prior to its use (abstract)

- The p-values for table 1 should be listed

- The impact of shutdown need to be addressed in the manuscript (for instance, was there an influx of patients admitted to the ICU/deployment to critical care services that would impact the care rendered to obstetric patients)

- Without having a clear understanding of the objective/aim of the study, it was difficulty to analyze the discussion and conclusion sections

- Consistency in the use of the word "COVID-19"; some parts as COVID19 and some as COVID-19

- Typo on line 199 of the manuscript

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Reviewer #4: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Reviewer Observation.docx

PLOS Glob Public Health. doi: 10.1371/journal.pgph.0002022.r003

Decision Letter 1

Ting Shi

25 Aug 2023

PGPH-D-23-00246R1

Using routine data to understand adverse pregnancy and neonatal outcomes associated with the COVID-19 pandemic in Kampala, Uganda

PLOS Global Public Health

Dear Dr. Ouma,

Thank you for submitting your manuscript to PLOS Global Public Health. After careful consideration, we feel that it has merit but does not fully meet PLOS Global Public Health’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Oct 09 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at globalpubhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgph/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Ting Shi

Academic Editor

PLOS Global Public Health

Journal Requirements:

1. Please amend your online detailed Financial Disclosure statement. This is published with the article. It must therefore be completed in full sentences and contain the exact wording you wish to be published.

a) State the initials, alongside each funding source, of each author to receive each grant. For example: "This work was supported by the National Institutes of Health (####### to AM; ###### to CJ) and the National Science Foundation (###### to AM)."

b) State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

2. Please ensure that the funders and grant numbers match between the Financial Disclosure field and the Funding Information tab in your submission form. Note that the funders must be provided in the same order in both places as well.

3. Please update your online Competing Interests statement. If you have no competing interests to declare, please state: “The authors have declared that no competing interests exist.”

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: (No Response)

Reviewer #3: (No Response)

**********

2. Does this manuscript meet PLOS Global Public Health’s publication criteria? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented.

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: (No Response)

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: (No Response)

Reviewer #3: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS Global Public Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The manuscript is presented in a legible manner. The themes flowed easily into each other and did not need any additional explanation.

Reviewer #2: 1. Information is well presented, and the author tried to review the manuscript based on comments.

2. Stil the title and conclusion are not matched

3. Methodology and analysis describe more about the importance of the records system but not the finding and analysis.

4. The analysis table is good but does not explain it and make a conclusion.

5. What will be the recommendation of this research, and what is the way forward

6. What is explained about the dashboard, and why is it essential in the study

7. Data is analysed on the electronic record system, and how they get informed consent where recoding information was taken but not explained about the data analysis and presentation.

Reviewer #3: Dr. Ouma and colleagues present a revised version of their manuscript titled " Using routine data to understand adverse pregnancy and neonatal outcomes associated with the COVID-19 pandemic in Kampala, Uganda." The authors respond to some of the previous critiques. Key edits include the following: correcting the reported aOR in the abstract. Previous version did not include a hypothesis, the authors now included their hypotheses at the conclusion of the introduction. The authors added the limitation of not considering other comorbidities (potential confounders) on the reported association. The authors also clarify the meaning of obstetric complications

Additional comments:

• If data not available of whether a delivery was assisted or not, then I suggest to change SVD to VD as we do not know whether it is a spontaneous or not.

• Clarify any abbreviation in the Tables at the footnote, such as that in Table 2

• Line 217, remove “; most of the women were multi-gravida.)”.

• In table 1, authors should provide the frequency and percentage of missing data in the related categories, so reader can be clear about the proportion of missing data in each group.

• Lines 218-219, “There were more preterm births during and after COVID-19 lock-down period compared to the pre-lock down period; Table 1.”. I still disagree with this interpretation and I think this is misleading statement as more than half of data in the pre-lockdown are missing according to the Table in the first version of the manuscript

• Lines 349 -351 “Other limitations include the unavailability of important risk factors such as pre-existing diabetes 350 mellitus, hypertension, and cardiovascular diseases which are important risk factors for COVID-19 disease.” Correct that they are important risk factors for adverse maternal and pregnancy outcomes.

• Some references require editing.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: comment-2.docx

PLOS Glob Public Health. doi: 10.1371/journal.pgph.0002022.r005

Decision Letter 2

Ting Shi

11 Oct 2023

Using electronic medical records to understand the impact of SARS-CoV-2 lockdown measures on maternal and neonatal outcomes in Kampala, Uganda

PGPH-D-23-00246R2

Dear Dr Hookham,

We are pleased to inform you that your manuscript 'Using electronic medical records to understand the impact of SARS-CoV-2 lockdown measures on maternal and neonatal outcomes in Kampala, Uganda' has been provisionally accepted for publication in PLOS Global Public Health.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact globalpubhealth@plos.org.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Global Public Health.

Best regards,

Ting Shi

Academic Editor

PLOS Global Public Health

***********************************************************

Reviewer Comments (if any, and for reference):

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Level of Government restrictions on the spread of COVID-19.

    (PDF)

    S2 Table. Missing data pattern and model used.

    (PDF)

    Attachment

    Submitted filename: Reviewer Observation.docx

    Attachment

    Submitted filename: Response to Reviewers.docx

    Attachment

    Submitted filename: comment-2.docx

    Attachment

    Submitted filename: REBUTTAL LETTER.docx

    Data Availability Statement

    Data are available in a public, open access repository (Figshare) at St George's University, London. The link to the dataset is DOI: 10.24376/rd.sgul.22116965.


    Articles from PLOS Global Public Health are provided here courtesy of PLOS

    RESOURCES